Cystoid Macular Edema İn Both Eyes After Cataract Surgery

Year 2024, Volume: 16 Issue: 3, 89 - 91, 31.12.2024

Çağatay Çağlar , Elvan Küçükkömürcü

https://doi.org/10.35514/mtd.2024.118

Abstract

Pseudophakic cystoid macular edema is one of the most common complications following uncomplicated cataract surgery. In most cases, macular edema is benign, self-limiting, and recover spontaneously without visual detoriation; however, refractory cystoid edema and persistent cases may occur and decrease visual acuity.

Keywords

Cataract, Cystoid Macular Edema, Pseudophakia

Katarakt Cerrahisi Sonrası Her İki Gözde Kistoid Maküler Ödem

Abstract

Psödofakik kistoid makula ödemi, komplikasyonsuz katarakt cerrahisini takiben en sık görülen komplikasyonlardan biridir. Çoğu vakada, makula ödemi iyi huyludur, kendi kendini sınırlar ve görme bozukluğu olmadan kendiliğinden düzelir; ancak, dirençli kistoid ödem ve inatçı vakalar ortaya çıkabilir ve görme keskinliğini azaltabilir.

Keywords

Anahtar Sözcükler: Katarakt, Kistoid Maküler ödem, Psödofaki

References

• 1.Grzybowski A, Sikorski BL, Ascano FJ, Huerva V. Pseudophakic Cystoid Macular Oedema. Clin. Interv. Aging. 2016;11:1221-1229.
• 2.Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL. Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg. 2007;33:1550-1558.
• 3.Hunter AA, Modjtahedi SP, Long K, Zawadzki R, Chin EK, Caspar JJ et al. Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoid macular edema. J Cataract Refract Surg. 2014;40:626-631.
• 4.Giarmoukakis AK, Blazaki SV, Bontzos GC, Plaka AD, Seliniotakis KN, Ioannidi LD et al. Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema. Ther Clin Risk Manag. 2020;16:1067-1074.
• 5.Guclu H, Gurlu VP. Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome. Int J Ophthalmol. 2019;12:258-267.
• 6.Orski M, Gawęcki M. Current Management Options in Irvine-Gass Syndrome: A Systemized Review. J ClinMed. 2021;10(19):4375.
• 7.Kuley B, Storey PP, Wibbelsman TD, Pancholy M, Zhang Q, Sharpe J et al. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. CurrEyeRes. 2021:1-7.
• 8.Erden B, Çakır A, Aslan AC, Bölükbaşı S, Elçioğlu MN. The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome. Ocul Immunol Inflamm. 2019;27:1235-1241.
• 9.Akay F, Isik MU, Akmaz B. Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome Int J Ophthalmol. 2020;13:1586-1591.
• 10.Lin CJ, Tsai YY. Use of Aflıbercept For The Management Of Refractory Pseudophakıc Macular Edema in Irvıne-Gass Syndrome And Lıterature Revıew. Retin Cases Brief Rep. 2018;12:59-62.